Trials / Sponsors / Bleeding and Clotting Disorders Institute Peoria, Illinois
Bleeding and Clotting Disorders Institute Peoria, Illinois
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia | Phase 1 | 2022-11-01 |